CT scan vs. needle biopsy: which is better for spotting pancreatic cancer?
NCT ID NCT07424456
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will compare two methods—triphasic CT scans and endoscopic ultrasound-guided biopsies—to see which one more accurately tells benign from malignant pancreatic lesions. Researchers will enroll 50 adults with pancreatic lesions found on initial imaging. The goal is to determine if the less invasive CT scan can match the accuracy of a biopsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that a CT scan is as accurate as a biopsy for diagnosing pancreatic lesions, potentially reducing the need for invasive procedures.
- What could go wrong
- This is a small, early study with only 50 participants, so results may not apply to everyone. The CT scan might still miss some cancers that a biopsy would catch.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CT SCAN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New heat therapy for pancreatic lesions tested in 100-Patient registry
- Nanomechanical biopsy could revolutionize pancreatic cancer care
- Can brain wave patterns predict epilepsy after a stroke?
- New biopsy device may improve pancreatic cancer diagnosis
- Are ER CT scans overused? new study investigates
- New CT scan could see lung blood flow without dye